Restriction fragment length polymorphisms in BF , C 2 , C 4 A , and C 4 B Enzyme Probe Variants

From the study of 52 families and 15 homozygous typing cells, 234 MHC complement haplotypes were characterized for features in the DNA of the complotype region: C2/Sst I (2.75, 2.70, 2.65, and 2.40 kb), BF/Taq I (6.6 and 4.5 kb), C4 59/Bgl II (15 and 4.5 kb), C4 59/Taq I (7.0, 6.4, 6.0 and 5.4 kb) and C4 39/Xba I/BamH I (11 and 417 kb) restriction fragment length polymorphisms (RFLP’s), by the presence or absence of C4A, C4B, CYP21A and CYP21B genes and by duplications. Nineteen (of over 1000 theoretically possible) complotype-RFLP constellations (CRC’s) were found. The 9 CRC’s with two C4 and CYP21 genes were designated A through I. CRC’s Bdup and Ddup were like B and D but had duplicated C4B-CYP21B genes. The remaining CRC’s had deletions of C4 and/or CYP21 genes and were designated Bdel, Cdel and the like. Individual complement alleles and complotypes were not randomly distributed among the CRC’s. Some complotypes, such as SC01, SC02 and FlC30, were restricted to only 1 CRC; others, such as SC31, FC31, and SC30, were found in several CRC’s. Some of the CRC’s contained a single complotype, others contained several. Remarkably, there are about 30 CRC-specified complotypes with frequencies of .01 or higher and 14 of .02 or higher. A number of evolutionary origins of complement alleles and complotypes are suggested by the relationships among CRC’s. Approximate normal frequencies of the undeleted CRC’s were A 5 .27, B 5 .19, Bdup 5 .02, C 5 .17, D 5 .07, Ddup 5 .02, E 5 .06, F 5 .05, and G 5 .02. Thus, CRC’s without deletions accounted for 88% of normal complotypes. Since the frequency of Bdel, with a deletion of C4A, was .12, 10 CRC’s accounted for all observed normal caucasian MHC haplotypes. Human Immunology 57, 27–36 (1997). © American Society for Histocompatibility and Immunogenetics, 1997. Published by Elsevier Science Inc. ABBREVIATIONS RFLP restriction fragment length polymorphism CRC complotype-RFLP constellation EDTA ethylene diamine tetraacetate

[1]  P. Schneider,et al.  Polymerase chain reaction analysis of the Xba I polymorphism of the human complement C4 genes provides evidence for strong haplotype conservation. , 1995, Human immunology.

[2]  P. Schneider,et al.  Length polymorphism of the human complement component C4 gene is due to an ancient retroviral integration. , 1995, Experimental and clinical immunogenetics.

[3]  A. Ahmed,et al.  Major histocompatibility complex susceptibility genes for dermatitis herpetiformis compared with those for gluten-sensitive enteropathy , 1993, The Journal of experimental medicine.

[4]  D R Bentley,et al.  A variable number of tandem repeats locus within the human complement C2 gene is associated with a retroposon derived from a human endogenous retrovirus , 1992, The Journal of experimental medicine.

[5]  P Ronco,et al.  A restriction fragment of the C2 gene is a unique marker for C2 deficiency and the uncommon C2 allele C2*B (a marker for type 1 diabetes). , 1991, The Journal of clinical investigation.

[6]  J. Volanakis,et al.  Allelic associations of multiple RFLPs of the gene encoding complement protein C2. , 1990, American journal of human genetics.

[7]  R. Campbell,et al.  Enhanced resolution of the SstI polymorphic variants of the C2 locus: description of a new size class. , 1989, Human immunology.

[8]  G. Pulverer,et al.  The BF F subtypes are detectable in the Ba fragment of factor B. , 1989, Forensic science international.

[9]  B. Dupont,et al.  Description of the Reference Panel of B-Lymphoblastoid Cell Lines for Factors of the HLA System: The B-Cell Line Panel Designed for the Tenth International Histocompatibility Workshop , 1989 .

[10]  L. Truedsson,et al.  The distribution of human C4 DNA variants in relation to major histocompatibility complex alleles and extended haplotypes. , 1988, Human immunology.

[11]  H. Orr,et al.  Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[12]  I. Dunham,et al.  Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Campbell,et al.  Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity. , 1986, The EMBO journal.

[14]  E. Sim,et al.  Phenotyping of human complement component C4, a class-III HLA antigen. , 1986, The Biochemical journal.

[15]  H. Colten,et al.  Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. , 1986, The Journal of clinical investigation.

[16]  D. Bentley,et al.  C2 and factor B: structure and genetics. , 1986, Biochemical Society symposium.

[17]  A. Cambon-Thomsen,et al.  A DNA restriction fragment length polymorphism in the complement region of the human MHC shows an absolute correlation with polymorphism of complement factor B(Bf) defined by isoelectric focusing. , 1985, European journal of immunogenetics.

[18]  K. Belt,et al.  Deletion of complement C4 and steroid 21‐hydroxylase genes in the HLA class III region. , 1985, The EMBO journal.

[19]  J. Strominger,et al.  Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Campbell,et al.  Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[21]  K. Gabbay,et al.  Extended major histocompatibility complex haplotypes in type I diabetes mellitus. , 1984, The Journal of clinical investigation.

[22]  K. Belt,et al.  The structural basis of the multiple forms of human complement component C4 , 1984, Cell.

[23]  D. Bentley,et al.  A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B , 1984, Nature.

[24]  H. Colten,et al.  DNA polymorphism of the C4 genes. A new marker for analysis of the major histocompatibility complex. , 1984, The New England journal of medicine.

[25]  R. Campbell,et al.  Internal homologies of the Ba fragment from human complement component Factor B, a class III MHC antigen. , 1984, The EMBO journal.

[26]  E. Yunis,et al.  Serum Complement ‘Supergenes' of the Major Histocompatibility Complex in Man (Complotypes) , 1983, Vox sanguinis.

[27]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[28]  D. Patzelt,et al.  Isoelectrofocusing in the Study of the Bf System: Existence of Two Common Subtypes of the BfF Allele 1 , 1983, Vox sanguinis.

[29]  Y. Teng,et al.  Subtyping of properdin factor B (Bf) by isoelectrofocusing. , 1982, Human heredity.

[30]  C. Alper,et al.  Inherited structural polymorphism of the fourth component of human complement. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Atkinson,et al.  Mapping of the HLA locus controlling C2 structural variants and linkage disequilibrium between alleles C22 and Bw15 , 1976 .

[32]  P. Lachmann,et al.  Allotypes of Complement Components in Man , 1976, Transplantation reviews.

[33]  C. Alper.  Inherited structural polymorphism in human C2: evidence for genetic linkage between C2 and Bf , 1976, The Journal of experimental medicine.

[34]  E. Southern.  Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.

[35]  P Chambon,et al.  Isolation of high-molecular-weight DNA from mammalian cells. , 1973, European journal of biochemistry.

[36]  C. Alper,et al.  GENETIC POLYMORPHISM IN HUMAN GLYCINE-RICH BETA-GLYCOPROTEIN , 1972, The Journal of experimental medicine.